Table of Contents

Articles

• You have access

  Interaction of β-l-2′,3′-dideoxy-2′,3′-didehydro-5-fluoro-CTP with Human Immunodeficiency Virus-1 Reverse Transcriptase and Human DNA Polymerases: Implications for Human Immunodeficiency Virus Drug Design

  Marina Kukhanova, Xiuyan Li, Shu-Hui Chen, Ivan King, Terrence Doyle, William Prusoff and Yung-Chi Cheng

  Molecular Pharmacology May 1998, 53 (5) 801-807;
• You have access

  Differential Uncoupling of A₁ Adenosine and D₂ Dopamine Receptors by Suramin and Didemethylated Suramin (NF037)

  Maria Waldhoer, Elisa Bofill-Cardona, Graeme Milligan, Michael Freissmuth and Christian Nanoff

  Molecular Pharmacology May 1998, 53 (5) 808-818;
• You have access

  Cisplatin- and Paclitaxel-Induced Apoptosis of Ovarian Carcinoma Cells and the Relationship between Bax and Bak Up-Regulation and the Functional Status of p53

  Neil A. Jones, Jonathon Turner, Amanda J. McIlwrath, Robert Brown and Caroline Dive

  Molecular Pharmacology May 1998, 53 (5) 819-826;
• You have access

  A Role for a Wortmannin-Sensitive Phosphatidylinositol-4-Kinase in the Endocytosis of Muscarinic Cholinergic Receptors

  Scott D. Sorensen, Daniel A. Linseman, Edward L. McEwen, Anne M. Heacock and Stephen K. Fisher

  Molecular Pharmacology May 1998, 53 (5) 827-836;
• You have access

  Thrombin and Phorbol Esters Potentiate G_s-Mediated cAMP Formation in Intact Human Erythroid Progenitors via Two Synergistic Signaling Pathways Converging on Adenylyl Cyclase Type VII

  M. Haslauer, K. Baltensperger and H. Porzig

  Molecular Pharmacology May 1998, 53 (5) 837-845;
• You have access

  DNA Interactions of a Novel Platinum Drug, cis-[PtCl(NH₃)₂(N7-Acyclovir)]⁺

  Zdenka Balcarová, Jana Kaspárková, Alena Zákovská, Olga Nováková, Maria F. Sivo, Giovanni Natile and Viktor Brabec

  Molecular Pharmacology May 1998, 53 (5) 846-855;
• You have access

  Agonist Interactions with Chimeric and Mutant β₁- and β₃-Adrenergic Receptors: Involvement of the Seventh Transmembrane Region in Conferring Subtype Specificity

  James G. Granneman, Kristine N. Lahners and Ying Zhai

  Molecular Pharmacology May 1998, 53 (5) 856-861;
• You have access

  Guanine Nucleotide-Sensitive Inhibition of L-Type Ca²⁺ Current by Lysosphingolipids in RINm5F Insulinoma Cells

  Herbert M. Himmel, Dagmar Meyer zu Heringdorf, Bernd Windorfer, Chris J. van Koppen, Ursula Ravens and Karl H. Jakobs

  Molecular Pharmacology May 1998, 53 (5) 862-869;
• You have access

  Location of a High Affinity Zn²⁺ Binding Site in the Channel of α1β1 γ-Aminobutyric Acid_A Receptors

  Jeffrey Horenstein and Myles H. Akabas

  Molecular Pharmacology May 1998, 53 (5) 870-877;
• You have access

  Binding Sites and Transduction Process of the Cholecystokinin_B Receptor: Involvement of Highly Conserved Aromatic Residues of the Transmembrane Domains Evidenced by Site-Directed Mutagenesis

  Alexandre Jagerschmidt, Nathalie Guillaume, Bernard P. Roques and Florence Noble

  Molecular Pharmacology May 1998, 53 (5) 878-885;
• You have access

  Inverse Agonists and Neutral Antagonists of Recombinant Human A₁ Adenosine Receptors Stably Expressed in Chinese Hamster Ovary Cells

  John C. Shryock, Mark J. Ozeck and Luiz Belardinelli

  Molecular Pharmacology May 1998, 53 (5) 886-893;
• You have access

  An Anionic Residue at Position 564 Is Important for Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor

  Shinji Kosugi, Toru Mori and Andrew Shenker

  Molecular Pharmacology May 1998, 53 (5) 894-901;
• You have access

  Isoform-Specific Inhibition of L-Type Calcium Channels by Dihydropyridines Is Independent of Isoform-Specific Gating Properties

  Hai Hu and Eduardo Marban

  Molecular Pharmacology May 1998, 53 (5) 902-907;
• You have access

  A Comparison of Thermodynamic Parameters for Vinorelbine- and Vinflunine-Induced Tubulin Self-Association by Sedimentation Velocity

  Sharon Lobert, Jeffrey W. Ingram, Bridget T. Hill and John J. Correia

  Molecular Pharmacology May 1998, 53 (5) 908-915;
• You have access

  Characterization of the Allosteric Interactions between Antagonists and Amiloride Analogues at the Human α_2A-Adrenergic Receptor

  Ray A. Leppik, Sebastian Lazareno, Anita Mynett and Nigel J. M. Birdsall

  Molecular Pharmacology May 1998, 53 (5) 916-925;
• You have access

  Interferon-γ-Inhibitory Oligodeoxynucleotides Alter the Conformation of Interferon-γ

  Vandana Balasubramanian, Linh T. Nguyen, Sathyamangalam V. Balasubramanian and Murali Ramanathan

  Molecular Pharmacology May 1998, 53 (5) 926-932;
• You have access

  The Selectivity Filter of theN-Methyl-d-Aspartate Receptor: A Tryptophan Residue Controls Block and Permeation of Mg²⁺

  Keith Williams, Albert J. Pahk, Keiko Kashiwagi, Takashi Masuko, Nguyen D. Nguyen and Kazuei Igarashi

  Molecular Pharmacology May 1998, 53 (5) 933-941;
• You have access

  Kainate Receptors Exhibit Differential Sensitivities to (S)-5-Iodowillardiine

  Geoffrey T. Swanson, Tim Green and Stephen F. Heinemann

  Molecular Pharmacology May 1998, 53 (5) 942-949;
• You have access

  Agonist-Induced Up-Regulation of α4β2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition

  Paul Whiteaker, Christopher G. V. Sharples and Susan Wonnacott

  Molecular Pharmacology May 1998, 53 (5) 950-962;
• You have access

  Protean Agonism at α_2A-Adrenoceptors

  Christian C. Jansson, Jyrki P. Kukkonen, Johnny Näsman, Ge Huifang, Siegfried Wurster, Raimo Virtanen, Juha-Matti Savola, Vic Cockcroft and Karl E. O. Åkerman

  Molecular Pharmacology May 1998, 53 (5) 963-968;